Αποτελέσματα Αναζήτησης
18 Σεπ 2024 · General management – For patients with heart failure with preserved ejection fraction (HFpEF), the goals of treatment are to reduce HF symptoms, increase functional status, and reduce the risk of hospital admission.
- Wilson S Colucci, MD
Treatment and prognosis of heart failure with preserved...
- Cleland Jgf, Bunting Kv, Flather Md, Et Al. Beta-blockers for Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fraction: an Individual Patient-Level Analysis of Double-Blind Randomized Trials. Eur Heart J 2018; 39:26
Eur Heart J. 2006;27(19):2338. Epub 2006 Sep 8. AIMS Many...
- Schwartzenberg S, Redfield Mm, From Am, Et Al. Effects of Vasodilation in Heart Failure With Preserved Or Reduced Ejection Fraction Implications of Distinct Pathophysiologies on Response to Therapy. J Am Coll Cardiol 2012; 59:442
Medline ® Abstract for Reference 10 of 'Treatment and...
- Liao L, Jollis Jg, Anstrom Kj, Et Al. Costs for Heart Failure With Normal vs Reduced Ejection Fraction. Arch Intern Med 2006; 166:112
Preserved EF was defined as an EF≥50%. The 31 studies...
- Persson H, Lonn E, Edner M, Et Al. Diastolic Dysfunction in Heart Failure With Preserved Systolic Function: Need for Objective Evidence:Results From The Charm Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 2007; 49:687
The mode of death was cardiovascular in 60% (including 26%...
- Yancy Cw, Jessup M, Bozkurt B, Et Al. 2013 Accf/Aha Guideline for The Management of Heart Failure: a Report of The American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62:E147
Heart failure: what does ejection fraction have to do with...
- Ahmed A, Rich Mw, Fleg Jl, Et Al. Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial. Circulation 2006; 114:397
METHODS AND RESULTS Forty-four patients with heart failure...
- Hasenfuß G, Hayward C, Burkhoff D, Et Al. a Transcatheter Intracardiac Shunt Device for Heart Failure With Preserved Ejection Fraction (Reduce Lap-Hf): a Multicentre, Open-Label, Single-Arm, Phase 1 Trial. Lancet 2016; 387:1298
BACKGROUND Heart failure with preserved ejection fraction...
- Wilson S Colucci, MD
19 Μαρ 2024 · Therapeutic Interventions in Heart Failure with Preserved Ejection Fraction. The goals of therapy for HFpEF are to reduce symptoms, improve quality of life, prevent disease progression, reduce hospitalizations, and effectively manage underlying comorbidities.
30 Μαΐ 2024 · Patients with heart failure with preserved ejection fraction (HFpEF) have symptoms and signs of heart failure, with left ventricular ejection fraction (LVEF) ≥50%, not attributable to an underlying cause such as infiltrative cardiomyopathy, hypertrophic cardiomyopathy, valvular disease, pericardial disease, or high-output heart failure.
19 Απρ 2023 · Heart failure with preserved ejection fraction (HFpEF) is defined as signs and symptoms of HF with left ventricular EF (LVEF) ≥50%. Diagnosis and management of HFpEF needs multidisciplinary care involving primary care, cardiology, and HF specialists.
5 Οκτ 2021 · Heart failure with preserved ejection fraction (HFpEF) diagnosis requires the presence of heart failure symptoms, evidence of elevated filling pressures, and the absence of an alternative explanation for symptoms.
1 Νοε 2017 · Heart failure with preserved ejection fraction should be suspected in patients with typical symptoms (e.g., fatigue, weakness, dyspnea, orthopnea, paroxysmal nocturnal dyspnea,...
3 Φεβ 2020 · SUMMARY. Heart failure with preserved ejection fraction is a highly heterogenous disease. There is emerging evidence that treatment should be tailored to the individual’s associated comorbidities. No current algorithms exist for the management of heart failure with preserved ejection fraction.